AMG National Trust Bank Has $7.42 Million Stake in CVS Health Corporation (NYSE:CVS)

AMG National Trust Bank lifted its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 9.7% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 109,512 shares of the pharmacy operator's stock after purchasing an additional 9,654 shares during the quarter. AMG National Trust Bank's holdings in CVS Health were worth $7,419,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently modified their holdings of CVS. McIlrath & Eck LLC grew its stake in shares of CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after purchasing an additional 174 shares in the last quarter. Park Square Financial Group LLC acquired a new stake in shares of CVS Health in the fourth quarter valued at $43,000. PARK CIRCLE Co lifted its holdings in shares of CVS Health by 42.9% in the fourth quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator's stock valued at $45,000 after buying an additional 300 shares during the period. Strategic Investment Solutions Inc. IL lifted its holdings in shares of CVS Health by 77.2% in the fourth quarter. Strategic Investment Solutions Inc. IL now owns 1,024 shares of the pharmacy operator's stock valued at $46,000 after buying an additional 446 shares during the period. Finally, Ball & Co Wealth Management Inc. acquired a new stake in shares of CVS Health in the fourth quarter valued at $49,000. Institutional investors own 80.66% of the company's stock.

Insiders Place Their Bets

In other news, Director Guy P. Sansone bought 1,570 shares of the stock in a transaction dated Thursday, June 5th. The stock was bought at an average cost of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director owned 12,007 shares of the company's stock, valued at approximately $764,845.90. This represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. 1.22% of the stock is owned by corporate insiders.

CVS Health Stock Performance

NYSE:CVS traded down $1.36 during mid-day trading on Friday, hitting $61.94. 8,610,279 shares of the company's stock traded hands, compared to its average volume of 10,775,122. The firm has a 50 day moving average of $64.70 and a two-hundred day moving average of $63.00. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $72.51. The firm has a market capitalization of $78.36 billion, a price-to-earnings ratio of 14.78, a price-to-earnings-growth ratio of 0.89 and a beta of 0.57. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The company had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the company earned $1.31 EPS. On average, equities analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Tuesday, July 22nd will be issued a dividend of $0.665 per share. The ex-dividend date is Tuesday, July 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.29%. CVS Health's dividend payout ratio is 63.48%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on CVS shares. Cowen restated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Mizuho upped their target price on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Royal Bank Of Canada upped their target price on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a report on Monday, May 5th. UBS Group upped their target price on CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a report on Friday, May 2nd. Finally, Jefferies Financial Group upped their target price on CVS Health from $74.00 to $80.00 and gave the company a "buy" rating in a report on Monday, June 30th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $75.06.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.